Clinical trials
Lymphoma, Large-Cell, Anaplastic trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Bristol-Myers Squibb | 1 |
| European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Hoffmann-La Roche | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | 10 |
| Lymphoma | 4 |
| Granuloma, Plasma Cell | 3 |
| Hodgkin Disease | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Breast Neoplasms | 2 |
| Burkitt Lymphoma | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.